DE69811962D1 - Substituierte 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindoline und ihre verwendung zur verminderung des tnfa spiegels - Google Patents

Substituierte 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindoline und ihre verwendung zur verminderung des tnfa spiegels

Info

Publication number
DE69811962D1
DE69811962D1 DE69811962T DE69811962T DE69811962D1 DE 69811962 D1 DE69811962 D1 DE 69811962D1 DE 69811962 T DE69811962 T DE 69811962T DE 69811962 T DE69811962 T DE 69811962T DE 69811962 D1 DE69811962 D1 DE 69811962D1
Authority
DE
Germany
Prior art keywords
dioxo
fluoropiperidin
isoindoline
reduce
tnfa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69811962T
Other languages
English (en)
Other versions
DE69811962T2 (de
Inventor
W Muller
I Stirling
Shen-Chu Chen
Hon-Wah Man
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celgene Corp
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/976,140 external-priority patent/US5874448A/en
Priority claimed from US09/042,274 external-priority patent/US5955476A/en
Application filed by Celgene Corp filed Critical Celgene Corp
Application granted granted Critical
Publication of DE69811962D1 publication Critical patent/DE69811962D1/de
Publication of DE69811962T2 publication Critical patent/DE69811962T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69811962T 1997-11-18 1998-11-17 Substituierte 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindoline und ihre verwendung zur verminderung des tnfa spiegels Expired - Lifetime DE69811962T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/976,140 US5874448A (en) 1997-11-18 1997-11-18 Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levels
US09/042,274 US5955476A (en) 1997-11-18 1998-03-13 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels
PCT/US1998/024453 WO1999046258A1 (en) 1998-03-13 1998-11-17 SUBSTITUTED 2-(2,6-DIOXO-3-FLUOROPIPERIDIN-3-YL)-ISOINDOLINES AND THEIR USE TO REDUCE TNFα LEVELS

Publications (2)

Publication Number Publication Date
DE69811962D1 true DE69811962D1 (de) 2003-04-10
DE69811962T2 DE69811962T2 (de) 2003-08-28

Family

ID=26719049

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69834668T Expired - Lifetime DE69834668T2 (de) 1997-11-18 1998-11-17 Substituierte 2-(2,6-dioxo-3-fluoropiperidine-3-yl)-isoindoline und ihre Verwendung zum reduzieren des TNF-alpha spiegels
DE69811962T Expired - Lifetime DE69811962T2 (de) 1997-11-18 1998-11-17 Substituierte 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindoline und ihre verwendung zur verminderung des tnfa spiegels

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69834668T Expired - Lifetime DE69834668T2 (de) 1997-11-18 1998-11-17 Substituierte 2-(2,6-dioxo-3-fluoropiperidine-3-yl)-isoindoline und ihre Verwendung zum reduzieren des TNF-alpha spiegels

Country Status (14)

Country Link
EP (3) EP1062214B1 (de)
AT (2) ATE233753T1 (de)
AU (1) AU752958B2 (de)
CY (1) CY1106100T1 (de)
CZ (1) CZ299808B6 (de)
DE (2) DE69834668T2 (de)
DK (1) DK1308444T3 (de)
ES (2) ES2192342T3 (de)
FI (1) FI20001192A (de)
HK (1) HK1054381B (de)
NO (1) NO318737B1 (de)
PT (1) PT1308444E (de)
SI (1) SI1308444T1 (de)
SK (1) SK7382000A3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299253B6 (cs) * 1998-03-16 2008-05-28 Celgene Corporation Isoindolinový derivát, jeho použití pro výrobu léciva a farmaceutická kompozice tento derivát obsahující
US20050100529A1 (en) * 2003-11-06 2005-05-12 Zeldis Jerome B. Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1531492A (en) * 1991-02-14 1992-09-15 Rockefeller University, The Method for controlling abnormal concentration tnf alpha in human tissues
US5629327A (en) * 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
DE4422237A1 (de) * 1994-06-24 1996-01-04 Gruenenthal Gmbh Verwendung von Lactamverbindungen als pharmazeutische Wirkstoffe
DE19613976C1 (de) * 1996-04-09 1997-11-20 Gruenenthal Gmbh Thalidomid-Prodrugs mit immunmodulatorischer Wirkung
HU228769B1 (en) * 1996-07-24 2013-05-28 Celgene Corp Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and their use for production of pharmaceutical compositions for mammals to reduce the level of tnf-alpha
ES2339425T3 (es) * 1996-07-24 2010-05-20 Celgene Corporation 2-(2,6-dioxopiperidin-3-il)-ftalimidas y -1-oxoisoindolinas sustituidas y procedimiento para reducir los niveles de tnf-alfa.
US5635517B1 (en) * 1996-07-24 1999-06-29 Celgene Corp Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines

Also Published As

Publication number Publication date
EP1062214A1 (de) 2000-12-27
EP1308444A1 (de) 2003-05-07
DE69811962T2 (de) 2003-08-28
CY1106100T1 (el) 2011-06-08
CZ299808B6 (cs) 2008-12-03
CZ20001822A3 (cs) 2000-11-15
AU1413899A (en) 1999-09-27
ATE327228T1 (de) 2006-06-15
PT1308444E (pt) 2006-08-31
SK7382000A3 (en) 2000-12-11
NO318737B1 (no) 2005-05-02
HK1054381A1 (en) 2003-11-28
AU752958B2 (en) 2002-10-03
ES2262753T3 (es) 2006-12-01
DK1308444T3 (da) 2006-09-18
EP1710242A1 (de) 2006-10-11
ES2192342T3 (es) 2003-10-01
SI1308444T1 (sl) 2007-04-30
FI20001192A (fi) 2000-07-14
EP1308444B1 (de) 2006-05-24
DE69834668D1 (de) 2006-06-29
DE69834668T2 (de) 2007-01-11
HK1054381B (zh) 2006-10-13
ATE233753T1 (de) 2003-03-15
NO20002529D0 (no) 2000-05-16
EP1062214B1 (de) 2003-03-05
NO20002529L (no) 2000-06-30

Similar Documents

Publication Publication Date Title
TR200002627T2 (tr) İkameli 2-(2,6- (Diokso-3-floropiperidin-3-İI) -izoindolinler ve TNF alfa seviyelerini düşürmek için kullanılmaları
ATE530542T1 (de) Amino substituierte 2-(2,6-dioxopiperidin-3-yl)- phthalimide zur verringerung der tnf-alpha-stufen
FI20000061A (fi) Substituoituja alkanohydroksaamihappoja ja menetelmä TNFalfa-tasojen alentamiseksi
DE69942627D1 (de) Verstärkungs- und Pegelregelungen von optischen Verstärkern in Kaskade
DE69723984D1 (de) Inhibitoren der produktion von s-cd23 und der secretion von tnf
DE69429660D1 (de) Brückenverstärker mit hohem Wirkungsgrad
NO983238D0 (no) Exodus kjemokin materialer og fremgangsmater
NO933652D0 (no) Ioderte benzoylacetater og -ketater
DE69811962D1 (de) Substituierte 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindoline und ihre verwendung zur verminderung des tnfa spiegels
DE69224680D1 (de) Elektroakustische Verstärker-Anordnung und Mikrofonanordnung zur Verwendung in der elektroakustischen Verstärker-Anordnung
DE59208370D1 (de) Stromrichterschaltungsanordnung und ihre Verwendung
DK73892A (da) Lampe til redningsvest eller -flaade
DE69732095D1 (de) Ionomerzusammensetzung und ihre verwendung
DE69015090T2 (de) Polyvinylester-Makromonomer und Verwendung davon.
ITMI940157A0 (it) Piano estensibile ed elevabile sinoronicamente
AT3966U3 (de) Hubtisch
KR970056822U (ko) 세라믹이 내장된 조리받침판
IT217447Z2 (it) Mobile articolato per ufficio o studio con piano ausiliario e cassettiera estraibili simultaneamente
KR980003065U (ko) 테이블 리프트를 가진 교량점검용 작업대
DE9318301U1 (de) Gegentakt-Leistungsverstärker
TR27860A (tr) Orta ve yüksek frekansli ocaklarda kullanilan termik tabanli tencereler.
IT1300117B1 (it) Tavolo con piano sollevabile
DE9404074U1 (de) Aus Holz gefertigtes Sargunterteil

Legal Events

Date Code Title Description
8364 No opposition during term of opposition